4d, e ) show that there is an overall trend that HSF1 levels are higher in AML patients than healthy controls and especially higher in AML with poor/complex cytogenetics or adverse outcomes.
← all excerpts
HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia.
1
—
—